Economics of chronic heart failure
Open Access
- 1 June 2001
- journal article
- review article
- Published by Wiley in European Journal of Heart Failure
- Vol. 3 (3), 283-291
- https://doi.org/10.1016/s1388-9842(01)00123-4
Abstract
Chronic heart failure (CHF) is now recognized as a major and escalating public health problem. The costs of this syndrome, both in economic and personal terms, are considerable. The prevalence of CHF...Keywords
This publication has 64 references indexed in Scilit:
- Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failure ∗The American Journal of Cardiology, 2000
- The Growing Healthcare Burden of CHFJournal of the Renin-Angiotensin-Aldosterone System, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Angiotensin Converting Enzyme (ACE) Inhibitors and Heart FailurePharmacoEconomics, 1999
- Costs Associated with Symptomatic Systolic Heart FailurePharmacoEconomics, 1999
- The Pharmacoeconomics of ACE Inhibitors in Chronic Heart FailurePharmacoEconomics, 1996
- Epidemiology of heart failure in the United StatesAmerican Heart Journal, 1993
- Effects of ACE Inhibitors on Heart Failure in The NetherlandsPharmacoEconomics, 1993
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- The prevalence of congestive heart failure in two rural communitiesJournal of Chronic Diseases, 1966